b'This is exactly the kind of thing the univer- Increasing our access to lab space, both forTerumo Blood andsity has needed to path their startups to goPerla and our research efforts, would beCell Technologies and get to the next level with the resourcesextremely valuable, she said. Right now, ImWith more than a century of success on its they need, she said. Callahan added thatlimited on the number of people I can employresume, when global medical device company the proximity to the rest of the CU Anschutzbased on the space I can put them in. Terumo Corporation reaches a milestone, its campus gives young companies an accessibleThe idea for Perla first came in 2015 and leda big deal.proving-ground for their technologies, spe- Lyons to connect with Callahan to discuss cifically the access to clinicians. potential business options. While the idea forThats exactly what happened when the com-The Startup Foundry offers a dedicateda novel therapeutic for breast cancer wasntpanys Colorado subsidiary, Terumo Blood and environment for companies outside of thequite ready at the time, the two have sinceCell Technologies, opened a state-of-the-art academic lab, giving founders a fresh per- reconnected as Perla looks for lab spacemanufacturing plant in Littleton earlier this spective and offering new opportunities forto accelerate its growth. Lyons said Perlayear. The $250 million investment was monu-cross collaboration, added Baler.is prioritizing finding space that combinesmental for the company, said Cynthia Hougum,The company plans to hire 300 employees for the office and lab sections as they prepare forGeneral Manager, Plasma Innovations, Terumo$250M manufacturing facility in Douglas County.For Perla Therapeutics Co-Founder andBlood and Cell Technologies.Co-Director of the scientific advisory boardregulatory applications.Technologies is a medical technology company Traci Lyons, Ph.D., the Startup FoundryAs they consider the Startup Foundry andThis is the biggest investment that Terumospecializing in products, software and services presents an interesting opportunity to helpother spaces, Lyons said additional lab expan- Corporation has done in their 101 years,for blood component collection, therapeutic advance her company. In addition to hersion and collaborations, like CU Innovationsshe said. apheresis and cellular technologies.role with Perla, Lyons runs a breast cancerand the CU Anschutz Medical Campus, areProduction at the 170,000-square-foot plantThe company already had over 50 years of researchprogramandisanAssociatekey to future bioscience growth in Colorado. serves source plasma collections customersroots in Colorado when it considered expan-Professor of Medical Oncology at the CUTo increase our ability as scientists to com- with single-use collection sets for the com- sion to meet the market needs for blood School of Medicine. In those roles, shes alsomercialize what we find in the lab is crucialpanys recently FDA-cleared Rika Plasmacomponent collection. The company has feeling the lab crunch. for the health of patients, she said. Donation System. Terumo Blood and Cellnearly 7,000 employees globally and about 2,000 in Colorado, making it one of the largest bioscience employers in the state. To date, the company has been granted 750 patents,By doing this, this officially starts the limited with 150 additional still pending. Hougummarket release, and we will do numerous said they originally looked at adding ontocollections in Aurora, she said, before the LIFE SCIENCES PRACTICE GROUP GROWING the companys Lakewood headquarters tocompany expands its rollout across the U.S.accommodate this growth, but ultimatelyUltimately, Colorado plays a crucial role in decided they would need a new, high-techTerumos story, both with this plasma col-facility to meet their impending needs. lection technology and its record-breaking AND NEED MORE LAB SPACE? We knew that to meet the industry growth wedinfrastructure investment. Hougum has need to build a facility to produce single-usehigh hopes for Terumos further growth in[Expansion] separations sets for this process, she said,the state.adding that Colorado was going to be the siteWe looked at [expansion] from the businesshere in Colorado WE CAN HELP for this expansion. That was always the plan. continuity side and having it here in Colorado After 14 months of building during thewas the right thing to do, she said. was the right Real Estate StrategySite Selection pandemic, the facility opened this springInvesting in Colorados thing to do. Lease Negotiations and Terumo has plans to hire nearly 300InfrastructureLabor Analytics employees to staff its new Littleton plant. And, in August, Terumo reached another signifi- The breadth of life sciences work in ColoradoCYNTHIA HOUGUM, PH.D. Project ManagementSVP & GENERAL MANAGER,cant milestone in Colorado related to its Rikagives us a preview of the speed, precision,PLASMA INNOVATIONSIncentives & ExpansionTEAM PAGE technology. The company completed the firstand personalization we can expect fromTERUMO BLOOD AND CELL TECHNOLOGIESplasma donation using the new system in ahealthcare in the coming years. Everything plasma collection center in Aurora, operatedfrom rapid, point-of-care testing, to targeted STEVE BILLIGMEIER ROB BAIN SID DIXON by CSL Plasma, a global leader in plasmacancer treatments, to cell and gene therapies Vice Chairman Senior Director Senior Director+1 303 813 6413 +1 303 813 6452 +1 303 312 4273 collections. This is just the first step for anto treat disease, to AI-enabled tools to assess steve.billigmeier@cushwake.com rob.bain@cushwake.com sidney.dixon@cushwake.comexciting future, Hougum said. and predict health. Its an exciting time to build the future for health innovation. 8 BIOSCIENCECOLORADO 2022-2023 2022-2023 BIOSCIENCECOLORADO 9'